- Quintiles reported second quarter 2014 earnings with several highlights: - Net new business growth of 21.2% and book-to-bill ratios above 1 for both segments. - Service revenue growth of 9.7% with IHS at 15.6% growth. - Adjusted income from operations up 14.4% and margin expanded 60 bps. - Diluted adjusted EPS increased 30.0% year-over-year. - Guidance for 2014 reiterated with service revenue growth of 10.3-11.3% and diluted adjusted EPS growth of 22.4-27.1%.

1. Copyright © 2014 Quintiles
July 31, 2014
Second Quarter 2014
Earnings Call

2. 2
Forward Looking Statements and
Use of Non-GAAP Financial Measures
This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933,
as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements
reflect, among other things, the Company’s current expectations and anticipated results of operations, all of which are
subject to known and unknown risks, uncertainties and other factors that may cause actual results, performance or
achievements, market trends or industry results to differ materially from those expressed or implied by such forward-
looking statements. Therefore, any statements contained herein that are not statements of historical fact may be
forward-looking statements and should be evaluated as such. Without limiting the foregoing, the words “anticipates,”
“believes,” “estimates,” “expects,” “intends,” “may,” “plans,” “projects,” “should,” “guidance,” “targets,” “will” and the
negative thereof and similar words and expressions are intended to identify forward-looking statements. Actual results
may differ materially from the Company’s expectations due to a number of factors, including that most of the
Company’s contracts may be terminated on short notice, the Company may be unable to maintain large customer
contracts or to enter into new contracts, the Company may under-price its contracts, overrun its cost estimates, or fail to
receive approval for or experience delays in documenting change orders, the historical indications of the relationship of
backlog to revenues may not be indicative of their future relationship, the Company is subject to the complex and
changing regulatory and international environments in which the Company operates, the Company may be unable to
successfully identify, acquire and integrate businesses, the Company’s substantial indebtedness, and other risks more
fully set forth in the Company's filings with the SEC, including the Company’s annual report on Form 10-K for the fiscal
year ended December 31, 2013, filed with the SEC on February 13, 2014, as such factors may be amended or updated
from time to time in the Company’s periodic filings with the SEC, which are accessible on the SEC's website at
www.sec.gov. The Company assumes no obligation to update any forward-looking statement after the date of this
presentation, whether as a result of new information, future developments or otherwise.
This presentation includes financial measures not prepared in accordance with accounting principles generally
accepted in the United States (“GAAP”). Management believes that these non-GAAP financial measures provide useful
supplemental information to management and investors regarding the underlying performance of the Company’s
business operations and are more indicative of core operating results as they exclude certain items whose fluctuations
from period-to-period do not necessarily correspond to changes in the core operations of the Company’s
business. Investors and potential investors are encouraged to review the reconciliations of the non-GAAP financial
measures to their most directly comparable GAAP measures attached to this presentation.

3. 3
Second Quarter – New Business
We continue to see strength in the market across both of our segments
• 21.2% net new business growth
• 7 accounts that exceed $100 million or more in net new business
• $10.26 billion of diversified backlog with over 500 pharmaceutical customers
• Integrated Healthcare Services trailing 4 quarter book to bill ratio of 1.56
Net New Business Net New Business
(billions of dollars) (billions of dollars)
Product Development $0.87 1.11x $1.87 1.21x
Integrated Healthcare
Services
$0.36 1.42x $0.63 1.29x
Total $1.23 1.19x $2.50 1.23x
Three Months Ended June 30, 2014
Book-to-Bill
Six Months Ended June 30, 2014
Book-to-Bill

4. 4
Financial Highlights and Other Metrics
Second Quarter 2014 Highlights
 8.6% constant currency service revenue growth and 9.7% at actual exchange rates
 IHS segment service revenue growth of 15.1% at constant currency and 15.6% at actual
exchange rates
 14.4% growth in adjusted income from operations
 60 basis points of expansion in adjusted income from operations margin
 30.0% increase in Diluted Adjusted EPS
1 Diluted Adjusted EPS is represented in dollars.
Reconciliations of the non-GAAP measures adjusted income from operations, adjusted income from operations margin, adjusted
EBITDA, adjusted net income attributable to Quintiles, and diluted adjusted earnings per share to the corresponding GAAP measures
are attached in the Supplemental Information section of this presentation.
(millions of dollars) 2014 2013 Change 2014 2013 Change
Net New Business 1,228.0$ 1,014.0$ 21.2% 2,503.0$ 2,259.0$ 10.8%
Service Revenues 1,035.5$ 944.2$ 9.7% 2,040.8$ 1,871.7$ 9.0%
Adjusted Income from Operations 141.9$ 124.1$ 14.4% 284.3$ 242.5$ 17.2%
Adjusted Income from Operations Margin 13.7% 13.1% 60 bps 13.9% 13.0% 90 bps
Adjusted EBITDA 171.8$ 149.1$ 15.2% 343.2$ 292.1$ 17.5%
Adjusted Net Income Attributable to Quintiles 85.7$ 62.9$ 36.2% 176.7$ 120.5$ 46.6%
Diluted Adjusted EPS1
0.65$ 0.50$ 30.0% 1.33$ 0.98$ 35.7%
Three Months Ended June 30 Six Months Ended June 30

5. 5
Segment Performance
Service Revenues and Income from Operations
$Millions$Millions
Product Development
0
200
400
600
800
$781.2
$724.2
$158.4 $136.1
0
200
400
600 $488.8
$441.2
$Millions
0
100
200
300 $254.3
$220.0
$11.7
$Millions
Integrated Healthcare Services
Certain costs are not allocated to the Company’s segments and are reported as general corporate and unallocated expenses. These costs primarily consist of share-based compensation and
expenses for corporate overhead functions such as finance, human resources, information technology, facilities and legal. The Company does not allocate restructuring or impairment charges to its
segments.
0
500
1,000
1,500
2,000 $1,552.0
$1,430.5
$319.0 $268.8
Actual Constant1 Actual Constant1
Revenue Growth 7.9% 6.7% Revenue Growth 15.6% 15.1%
Operating Income Growth 16.4% 11.3% Operating Income Growth (6.4%) 3.7%
Actual Constant1 Actual Constant1
Revenue Growth 8.5% 7.6% Revenue Growth 10.8% 11.5%
Operating Income Growth 18.7% 12.0% Operating Income Growth 10.1% 21.2%
1The constant currency calculation is provided in the Supplemental Information section of this presentation.
ThreeMonthsEnded
June30
SixMonthsEnded
June30
ThreeMonthsEnded
June30
SixMonthsEnded
June30
$12.5
$20.7 $18.7
2014 2013
Operating Income Margin 20.3% 18.8% Operating Income Margin 4.6% 5.7%
2014 2013
Operating Income Margin 20.6% 18.8% Operating Income Margin 4.2% 4.3%
Revenues Operating Income

6. 6
2014 Guidance Update
Service Revenues range of $4.20 billion to $4.24 billion
• 10.3% to 11.3% year over year growth range at forecasted exchange rates
Diluted Adjusted Earnings per share range of $2.57 to $2.67
• 22.4% to 27.1% year over year growth range at forecasted exchange rates
Annual Effective Income Tax Rate of approximately 30%
This financial guidance is based on the actual results for the first six month period of 2014 combined with our estimates for the following six months of
2014, assuming the June foreign currency exchange rates stay in effect for the remainder of the year and does not reflect the impact of any future
equity repurchases.
A reconciliation of forecasted diluted adjusted earnings per share to diluted GAAP net income per share is provided in the Supplemental Information
section of this presentation.
1
1

7. 7
Summary
• Good 2014 first half year results
• Capital deployment achievements
• Recognition during the quarter
 IHS returned to growth with 11.5% constant currency
service revenue growth
 Product Development executed consistently with
good revenue growth and improved productivity
 Consolidated net new business growth of 10.8%
 90 bps of adjusted operating margin expansion
 35.7% diluted adjusted EPS growth
 RFP pipeline strong
 Purchased 3.3 million shares
 Announced acquisition of Encore Health Resources
acquisition and closed on July 1, 2014
 Named to the Fortune 500
 Recognized as the Industry Leader in Phase I and
Phase IV by ISR
 Computerworld’s 100 Best Places to Work - 6th time
 Named to CIO 100 for Quintiles Infosario® platform
 Britain’s Healthiest Large Workplace
 Great Place to Work awards Europe and the UK
1
2
3

8. 8
Supplemental Information
Constant Currency Reconciliation
Contractual Revenue Currency Mix and Foreign
Exchange Analysis
Income Statement Non-GAAP Reconciliation
Adjusted EBITDA Reconciliation
Adjusted Net Income and EPS Reconciliation
Non-GAAP 2014 Guidance Reconciliation

9. 9
Constant Currency Reconciliation
Service Revenues and Income from Operations
Service revenues exchange impact equals the current period service revenues at actual rates less the current period service revenues for foreign currency
denominated contracts recalculated at the prior period exchange rates, while the exchange rate impacts on expenses equals the current period expenses at actual
rates less the current period expenses recalculated at the prior period exchange rates.
The segment detail presented above excludes general corporate and unallocated expenses and restructuring costs.
(millions of dollars)
Consolidated Actual
Exchange
Impact Constant Actual
Exchange
Impact Constant
Service Revenues 1,035.5$ 10.1$ 1,025.4$ 9.7% 1.1% 8.6%
Income from Operations 141.0$ 5.7$ 135.3$ 48.6% 6.0% 42.6%
Adjusted Income from Operations 141.9$ 5.7$ 136.2$ 14.4% 4.5% 9.9%
Adjusted Income from Operations Margin 13.7% 13.3%
Product Development
Service Revenues 781.2$ 8.9$ 772.3$ 7.9% 1.2% 6.7%
Income from Operations 158.4$ 6.9$ 151.5$ 16.4% 5.1% 11.3%
Income from Operations Margin 20.3% 19.6%
Integrated Healthcare Services
Service Revenues 254.3$ 1.2$ 253.1$ 15.6% 0.5% 15.1%
Income from Operations 11.7$ (1.2)$ 12.9$ (6.4%) -10.1% 3.7%
Income from Operations Margin 4.6% 5.1%
Three Months Ended June 30 Year on Year Growth
(millions of dollars)
Consolidated Actual
Exchange
Impact Constant Actual
Exchange
Impact Constant
Service Revenues 2,040.8$ 9.6$ 2,031.2$ 9.0% 0.5% 8.5%
Income from Operations 282.3$ 15.9$ 266.4$ 34.4% 7.6% 26.8%
Adjusted Income from Operations 284.3$ 15.9$ 268.4$ 17.2% 6.5% 10.7%
Adjusted Income from Operations Margin 13.9% 13.2%
Product Development
Service Revenues 1,552.0$ 12.6$ 1,539.4$ 8.5% 0.9% 7.6%
Income from Operations 319.0$ 17.9$ 301.1$ 18.7% 6.7% 12.0%
Income from Operations Margin 20.6% 19.6%
Integrated Healthcare Services
Service Revenues 488.8$ (3.0)$ 491.8$ 10.8% -0.7% 11.5%
Income from Operations 20.7$ (2.1)$ 22.8$ 10.1% -11.1% 21.2%
Income from Operations Margin 4.2% 4.6%
Year on Year GrowthSix Months Ended June 30

10. 10
Contractual Revenue Currency Mix
and Foreign Exchange Analysis
1 Other includes a mix of more than 40 currencies.
USD Sterling Euro Yen Other1
Total
2Q '14 $645.3 $84.3 $169.5 $107.6 $28.8 $1,035.5
% of total 63% 8% 16% 10% 3% 100%
2Q '13 $582.7 $65.1 $161.5 $96.7 $38.2 $944.2
% of total 62% 7% 17% 10% 4% 100%
2Q '14 Average Rate $1.66 $1.37 ¥102.77
2Q '13 Average Rate $1.54 $1.31 ¥98.75
% Increase (Decrease) 7.8% 4.9% (3.9%)
Consolidated Service Revenues (millions of dollars)
USD Sterling Euro Yen Other1
Total
YTD 2014 $1,241.8 $175.8 $357.3 $210.2 $55.7 $2,040.8
% of total 60% 9% 18% 10% 3% 100%
YTD 2013 $1,160.1 $140.3 $321.7 $192.4 $57.2 $1,871.7
% of total 62% 7% 17% 10% 4% 100%
YTD '14 Average Rate $1.67 $1.37 ¥102.44
YTD '13 Average Rate $1.54 $1.31 ¥95.52
% Increase (Decrease) 8.1% 4.4% (6.7%)
Consolidated Service Revenues (millions of dollars)

11. 11
Income Statement
GAAP – Non-GAAP Reconciliation
1Represents the Company’s change in its permanent reinvestment assertion during 2Q 2013 retroactively applied to1Q 2013 for the new
estimated annual effective income tax rate for 2013.
1
Six Months Ended June 30
(millions of dollars)
Selling,
General and
Administrative
Income
from
Operations
Net Income
Attributable
to Quintiles
Selling,
General and
Administrative
Income
from
Operations
Net Income
Attributable
to Quintiles
As Reported $ 438.3 $ 282.3 $ 175.3 $ 428.1 $ 210.1 $ 86.8
Adjustments
Restructuring Costs - 2.0 2.0 - 4.7 4.7
Management Fees - - - (27.7) 27.7 27.7
Loss on Extinguishment of Debt - - - - - 16.5
Tax Effect of Adjustments - - (0.6) - - (18.3)
Other Income Tax Adjusments1
- - - - - 3.1
Adjusted Non-GAAP Basis $438.3 $284.3 $176.7 $400.4 $242.5 $120.5
% of Service Revenues 21.5% 13.9% 8.7% 21.4% 13.0% 6.4%
2014 2013
Three Months Ended June 30
(millions of dollars)
Selling,
General and
Administrative
Income
from
Operations
Net Income
Attributable
to Quintiles
Selling,
General and
Administrative
Income
from
Operations
Net Income
Attributable
to Quintiles
As Reported $ 219.0 $ 141.0 $ 85.1 $ 228.8 $ 94.9 $ 38.5
Adjustments
Restructuring Costs - 0.9 0.9 - 2.8 2.8
Management Fees - - - (26.4) 26.4 26.4
Loss on Extinguishment of Debt - - - - - 16.5
Tax Effect of Adjustments - - (0.3) - - (17.1)
Other Income Tax Adjusments1
- - - - - (4.2)
Adjusted Non-GAAP Basis $219.0 $141.9 $85.7 $202.4 $124.1 $62.9
% of Service Revenues 21.2% 13.7% 8.3% 21.4% 13.1% 6.7%
2014 2013

12. 12
Reconciliation of Net Income Attributable to
Quintiles to Non-GAAP Adjusted EBITDA
(millions of dollars) 2014 2013 2014 2013
Net Income Attributable to Quintiles $ 85.1 $ 38.5 $ 175.3 $ 86.8
Income from Noncontrolling Interests - (0.1) - (0.3)
Interest Expense, Net 23.8 31.1 47.3 66.7
Income Tax Expense 32.4 8.8 69.8 41.0
Depreciation and Amortization 29.9 25.0 58.9 49.6
Restructuring Costs 0.9 2.8 2.0 4.7
Management Fees - 26.4 - 27.7
Loss on Extinguishment of Debt - 16.5 - 16.5
Other Income 3.1 0.6 (1.8) (1.8)
(Earnings) Losses from Unconsolidated Affiliates (3.4) (0.5) (8.3) 1.2
Non-GAAP Adjusted EBITDA $ 171.8 $ 149.1 $ 343.2 $ 292.1
% of Service Revenues 16.6% 15.8% 16.8% 15.6%
Three Months Ended June 30 Six Months Ended June 30

13. 13
Reconciliation of Net Income Attributable to
Quintiles to Non-GAAP Adjusted Net Income
and Diluted Adjusted EPS
1 EPS is represented in dollars.
2 The tax effect of adjustments was based on the income tax rate applicable to the respective transactions, which was 38.5%,
with the exception of restructuring costs which were tax effected at 36.5% and 20.1% during the three months ended June
30, 2014 and 2013, respectively, and 30.3% and 26.4% during the six months ended June 30, 2014 and 2013, respectively.
3 Represents the Company’s change in its permanent reinvestment assertion during 2Q 2013 retroactively applied to1Q 2013
for the new estimated annual effective income tax rate for 2013.
4 Diluted shares are represented in thousands.
(millions of dollars) 2014
EPS
1
2013
EPS
1
2014
EPS
1
2013
EPS
1
Net Income Attributable to Quintiles $ 85.1 0.64$ $ 38.5 0.30$ $ 175.3 1.32$ $ 86.8 0.71$
Restructuring Costs 0.9 0.01 2.8 0.02 2.0 0.02 4.7 0.04
Management Fees - - 26.4 0.21 - - 27.7 0.23
Loss on Extinguishment of Debt - - 16.5 0.13 - - 16.5 0.13
Tax Effect of Adjustments2
(0.3) - (17.1) (0.13) (0.6) (0.01) (18.3) (0.15)
Other Income Tax Adjustments3
- - (4.2) (0.03) - - 3.1 0.02
Non-GAAP Adjusted Net Income $ 85.7 0.65$ $ 62.9 0.50$ $ 176.7 1.33$ $ 120.5 0.98$
Number of Diluted Shares Outstanding4
132,042 126,578 132,541 122,659
Three Months Ended June 30 Six Months Ended June 30

14. 14
Non-GAAP 2014 Guidance Reconciliation
1 Restructuring costs are tax effected at approximately 30%.
1
Low High Low High
Net income attributable to Quintiles $328 - $344 $2.49 - $2.61
Restructuring costs 14 - 12 0.11 - 0.09
Tax effect of adjustments (4) - (4) (0.03) - (0.03)
Adjusted net income and diluted adjusted earnings per share $338 - $352 $2.57 - $2.67
Non-GAAP Adjusted
Net Income
(millions of dollars)
Diluted Adjusted
Earnings Per Share
1